Member Exclusive Drug approvals

New drug approvals: April 2018

April has seen some interesting drug approvals, including treatments for X-linked hypophosphatemia, idiopathic thrombocytopenic purpura and nausea; find out more in this round-up of the new therapies on the market.

Thumb untitled design
May 01, 2018

Please sign in or register for FREE

No comments yet.